Skip to main content
Caplight Logo









ZipBio

ZipBio

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.ziptx.bio/

Last Round

Seed

Sep 5, 2024

Total Funding Raised

$4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ZipBio is a biotechnology company that develops gene therapies and biologics by leveraging generative AI to create compact, multi-specific, and logic-gated therapeutic molecules.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Foundation

Keywords

generative AIprotein therapeuticsdrug discoveryde-novo protein designAI-driven drug discoveryprotein engineeringin silico drug designgene therapymultispecific proteinsbiotech startupcomputational biologyprecision medicinetherapeutic deliverybiologicsAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZipBio Comparables

Compare ZipBio with similar companies based on industry and business-model similarity.

ZipBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DenovAI Biotech
83%
Cassidy Bio
82%
AI Proteins
79%

ZipBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 5, 2024

Key People

Founding team and executive leadership

Ori Zelichov

Co-Founder, President & Chief Strategy Officer

Founding Team

Roee Farber

Co-Founder CEO

Founding Team

ZipBio Investors

Notable investors and investment history

ZipBio investors
InvestorRounds
NFXSeed
MoreVCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 725% MoM, from 228 to 1.9K.

  • Sep 5, 2024

    $4M round led by NFX

ZipBio Filings

Explore SEC and related filing metadata, where available.

ZipBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZipBio's valuation, stock price, and market status.

Is ZipBio a public or private company?

ZipBio is a private company.

What is the current stock price of ZipBio?

ZipBio is a private company with no public stock price. No recent secondary market data is available.

How much is ZipBio worth (valuation)?

Valuation information for ZipBio is not publicly available.

Can I buy ZipBio stock?

ZipBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZipBio's last funding round?

ZipBio's most recent funding round was Seed on September 5, 2024.

Who are the main investors in ZipBio?

Key investors in ZipBio include NFX.

Will ZipBio IPO soon?

No public IPO plans have been announced for ZipBio.

How can I track ZipBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZipBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range5
Year Founded2023
Last FundingSep 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?